BILLEV PHARMA ApS: Financial statements 2023
CVR: 81814813
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 29,072,533 and a net result of DKK 4,943,056 compared with DKK 6,013,157 the year before. That is a decrease of 3.6% compared with the year before. Equity in the 2023 report amounted to DKK 5,263,056. The solvency ratio was 58.8%. The company had 21 employees in the financial year.
- Gross Profit
- DKK 29,072,533
- Profit/Loss
- DKK 4,943,056
- Equity
- DKK 5,263,056
- Total Assets
- DKK 8,946,496
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 29.1 mio. | 4.9 mio. | 5.3 mio. | 21 |
| 2022 | - | 30.2 mio. | 6 mio. | 6.3 mio. | 21 |
| 2021 | - | 25.6 mio. | 5.5 mio. | 5.9 mio. | 19 |
| 2020 | - | 21.4 mio. | 3.8 mio. | 4.1 mio. | 16 |
| 2019 | - | 17.5 mio. | 2.5 mio. | 2.8 mio. | 14 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Anja Wencke van Arkens and Ulrikke Lynge Jensen. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees (2018). In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity in the 2026 report amounted to DKK 10,525,639.